{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:17:12Z","timestamp":1774120632346,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.pupt.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T02:17:46Z","timestamp":1361326666000},"page":"348-355","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of indacaterol and tiotropium in COPD patients according to\u00a0dyspnoea severity"],"prefix":"10.1016","volume":"26","author":[{"given":"Donald A.","family":"Mahler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"McBryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.02.006_bib1","unstructured":"Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated December 2011. http:\/\/www.goldcopd.org\/ [accessed 17.01.12]."},{"key":"10.1016\/j.pupt.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/bmj.2.5213.1665","article-title":"Standardized questionaires on respiratory symptoms","volume":"2","author":"Statement of a Medical Research Council Committee","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.pupt.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/arrd.1987.135.6.1229","article-title":"Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease","volume":"135","author":"Mahler","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.02.006_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1378\/chest.121.5.1434","article-title":"Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD","volume":"121","author":"Nishimura","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1183\/09031936.00191810","article-title":"Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD","volume":"38","author":"Buhl","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thx.2009.125435","article-title":"Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD","volume":"65","author":"Dahl","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.02.006_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.200910-1500OC","article-title":"Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium","volume":"182","author":"Donohue","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.02.006_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1183\/09031936.00045810","article-title":"Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison","volume":"37","author":"Kornmann","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A\u00a0self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/COPD-200050666","article-title":"The MCID of the transition dyspnea index is a total score of one unit","volume":"2","author":"Mahler","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0895-4356(02)00589-9","article-title":"Meaningful effect size and patterns of response of the transition dyspnea index","volume":"56","author":"Witek","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.pupt.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","article-title":"Minimal important difference of the transition dyspnoea index in a multinational clinical trial","volume":"21","author":"Witek","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's Respiratory Questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.rmed.2009.01.009","article-title":"Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade","volume":"103","author":"Evans","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1183\/09031936.98.12020363","article-title":"Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale","volume":"12","author":"Wedzicha","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.07-0703","article-title":"Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes","volume":"132","author":"Mahler","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.2005.brusascolett","article-title":"Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"61","author":"Brusasco","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.rmed.2011.02.008","article-title":"Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study","volume":"105","author":"Korn","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T14:53:21Z","timestamp":1539874401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1094553913000631"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.02.006","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}